Search

Heron Therapeutics Inc

Suletud

SektorTervishoid

0.35 -5.41

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.31

Max

0.37

Põhinäitajad

By Trading Economics

Sissetulek

2.6M

-5.5M

Müük

3M

38M

Aktsiakasum

-0.03

Kasumimarginaal

-14.573

Töötajad

128

EBITDA

2.1M

-5.5M

Dividendid

By Acuity

Järgmine tulemuste avaldamine

3. nov 2026

Turustatistika

By TradingEconomics

Turukapital

-27M

70M

Eelmine avamishind

5.76

Eelmine sulgemishind

0.35

Uudiste sentiment

By Acuity

67%

33%

286 / 340 Pingereas Healthcare

Heron Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

7. okt 2026, 23:55 UTC

News

Aptiv PLC shares traded modestly lower in after-hours action following UBS's Buy rating and a lowered price target of $57.

7. okt 2026, 23:51 UTC

News

Hilton Worldwide Holdings Inc is trading modestly lower in after-market hours, breaking a recent trend of higher daily closes amid broader market shifts.

7. okt 2026, 23:45 UTC

News

Pinterest Inc launched Beauty Guides, an AI tool for style communication, as shares advanced modestly in after-market trading, reaching over half a percent above Wednesday's close.

7. okt 2026, 23:45 UTC

News

Lattice Semiconductor Corp partners with Arm to enhance AI data center security, gaining slightly in after-market trading and showcasing at the OCP Global Summit 2026.

7. okt 2026, 23:45 UTC

News

EMCOR Group Inc. is trading modestly higher in after-market hours, supported by strong earnings of $547.3 million amid increased interest in data-center construction.

7. okt 2026, 23:45 UTC

News

Xpeng Inc's G9L model completed its first production trial in Austria, while shares are trading lower in after-market hours, below the 20-day moving average.

7. okt 2026, 23:41 UTC

News

Hims & Hers Health appoints Jon Franklin as Chief Accounting Officer, effective immediately, as shares move higher in after-market trading.

7. okt 2026, 23:40 UTC

News

Mid-America Apartment Communities Inc will release its Q3 2026 earnings on October 28, contributing to positive investor sentiment as shares rise in after-market trading.

7. okt 2026, 23:35 UTC

Social Media
News

IBM has advanced to Stage C of the DARPA Quantum Benchmarking Initiative, aiming for a fault-tolerant quantum computer by 2029, with shares roughly flat in after-market trading.

7. okt 2026, 23:35 UTC

Correlated Moves
News

Truist Financial shares are modestly lower in after-market trading following TD Cowen's Hold rating, reflecting broader declines in the Vanguard Morningstar Value ETF.

7. okt 2026, 23:30 UTC

News

Invitation Homes Inc. announced its Q3 2026 earnings release date for October 28, 2026, with shares moving modestly higher in after-market trading.

7. okt 2026, 23:20 UTC

News

U.S. Bancorp shares have moved higher in after-market trading following TD Cowen's resumption of coverage with a Buy rating.

7. okt 2026, 23:20 UTC

News

Avery Dennison Corp's shares advanced modestly in after-market trading, recovering from earlier losses and remaining near the lower end of their one-month trading range.

7. okt 2026, 23:20 UTC

News

UBS maintained its Buy rating on RPM International Inc, lowering its price target to $128, as shares gain slightly in after-market trading.

7. okt 2026, 23:15 UTC

News

APA Corp reported preliminary Q3 2026 financial data, including average realized oil prices of $87.50 in the U.S., with shares trading higher in after-market hours.

7. okt 2026, 23:11 UTC

News

The USD/DKK is trading modestly higher, supported by a weaker euro and concerns over European economic conditions amid rising oil prices and geopolitical tensions.

7. okt 2026, 23:11 UTC

News

Bitcoin fell as it approached the $83k to $84k range, following a failure to break $87k resistance and amid rising oil prices and Fed rate hike signals.

7. okt 2026, 23:11 UTC

News

Bitcoin is trading lower for a third consecutive session, nearing the $83k to $84k range amid $550 million in liquidations and rising oil prices.

7. okt 2026, 23:11 UTC

News

Ethereum is declining for a third straight session amid geopolitical tensions and a broader cryptocurrency sell-off, with Bitcoin liquidations around $550 million.

7. okt 2026, 23:11 UTC

News

Ethereum is trading lower amid geopolitical tensions and a broader cryptocurrency sell-off, with Bitcoin liquidations around $550 million contributing to market volatility.

7. okt 2026, 23:06 UTC

News
Social Media

Rivian Automotive Inc secured a $1 billion loan facility from Volkswagen Group, with shares rising slightly in after-market trading following the announcement.

7. okt 2026, 23:06 UTC

News

The USD/NOK is trading slightly higher as the Federal Reserve's September meeting minutes indicate strong support for another interest rate hike by year-end.

7. okt 2026, 23:06 UTC

Correlated Moves
News

Shell PLC's shares rose in after-market hours, buoyed by EOG Resources' strong performance and the company's collaboration with Airsys on energy-efficient cooling solutions.

7. okt 2026, 23:06 UTC

News

Liquidia Corporation's stock trades lower in after-market hours amid an investigation into potential securities law violations following a court ruling on United Therapeutics' patent.

7. okt 2026, 23:06 UTC

News

EUR/GBP is trading slightly lower, remaining flat since Tuesday's close, and positioned below its 20-day moving average amid Germany's industrial production recovery.

7. okt 2026, 23:06 UTC

News
Correlated Moves

The USD/PLN is trading modestly higher, influenced by retail commentary on the 101.80 level and the euro's decline against major currencies.

7. okt 2026, 23:06 UTC

News
Correlated Moves

The USD/CZK is trading modestly higher as the euro weakens amid economic concerns in Europe and signals of a potential Fed interest rate hike.

7. okt 2026, 23:05 UTC

News

Verizon Communications Inc is enhancing connectivity measures in response to Tropical Storm Isaias, contributing to a modest after-market hours gain in its shares.

7. okt 2026, 23:05 UTC

News

Coca-Cola Consolidated Inc traded modestly higher in after-market hours following the announcement of a new zero-sugar prebiotic soda, despite recent volatility.

7. okt 2026, 23:05 UTC

News

UBS reaffirms its Buy rating on BlackRock Inc, lowering the price target to $1.28K, as the stock remains flat in after-market trading.

Võrdlus sarnastega

Hinnamuutus

Heron Therapeutics Inc Prognoos

Hinnangu Konsensus

By TipRanks

Neutraalne

2 ratings

0

Osta

2

Hoia

0

Müü

Sentiment

By Acuity

286 / 340 Pingereas Tervishoid

Uudiste sentiment

Tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Heron Therapeutics Inc

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.